Next generation patient-derived, genetically-defined kidney and bladder cancer xenograft models for anti-cancer drug development

Adrian Gunaratne

Functional characterization of novel non-coding RNA transcripts in bladder cancer

Bladder

Surgery / Surgical oncology

James D Marks

Antibody Research Technology Center

Kidney, renal pelvis and ureter

Poul Sorensen

The Hace1 tumour suppressor--a novel regulator of the oxidative stress response

Kidney, renal pelvis and ureter

Pediatric oncology or childhood cancer

Philip A Beachy

Epithelial/stromal signaling in bladder and prostate cell proliferation

Prostate Bladder

Pathology

Investigator from Acondicionamiento Tarrasense Associacion

Laser Multiplexed Biosensor

Testis Prostate Ovary Kidney, renal pelvis and ureter Corpus uteri Cervix uteri Bladder

Mark Lewandoski

The Role of Fgf Signaling in Vertebrate Development 

Testis Prostate Kidney, renal pelvis and ureter Breast

Francois Dabis

A test for predicting the efficacy of common platinum drugs enabling personalized chemotherapy for bladder cancer patients

Trachea, bronchus and lung Bladder

Toni Choueiri

Genetic Predictors of Response to mTOR inhibitors in advanced Renal Cancer

Kidney, renal pelvis and ureter

Marc Brisson

Study and control of human papillomavirus related diseases (CANADA RESEARCH CHAIRHOLDER)

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri